Page last updated: 2024-08-21

oxazoles and methoxyhydroxyphenylglycol

oxazoles has been researched along with methoxyhydroxyphenylglycol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's5 (55.56)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berlin, I; Hergueta, T; Payan, C; Puech, AJ; Robin, L; Thiede, HM; Zimmer, R1
Garrick, NA; Linnoila, M; Murphy, DL; Seppala, T1
Deniker, P; Lesage, A; Lôo, H; Olié, JP; Poirier, MF; Rovei, V; Strolin Benedetti, M1
Dordain, G; Dostert, P; Eschalier, A; Lesage, A; Rovei, V; Strolin Benedetti, M; Zarifian, E1
Aubin, N; Curet, O; Damoiseau, G; Jarreau, FX; Rovei, V; Sontag, N1
Allain, H; Cimarosti, I; Curet, O; Dubruc, C; Durrieu, G; Gandon, JM; Jezequel, S; le Coz, F; Patat, A; Rosenzweig, P; Zieleniuk, I1
Curet, O; Dubruc, C; Durrieu, G; Legangneux, E; Patat, A; Rosenzweig, P; Zieleniuk, I1
Birk, KL; Cohen, AF; De Puy, ME; De Smet, M; Fisher, AL; Goldberg, MR; Musson, DG; Sterrett, A; Van Gerven, JM; Van Haarst, AD1
Guth, PS; Hendricson, AW1

Trials

6 trial(s) available for oxazoles and methoxyhydroxyphenylglycol

ArticleYear
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
    British journal of clinical pharmacology, 1990, Volume: 30, Issue:6

    Topics: Adult; Benzamides; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Psychometrics; Psychophysiology

1990
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
    L'Encephale, 1983, Volume: 9, Issue:4

    Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Kinetics; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Prolactin

1983
Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.
    European journal of clinical pharmacology, 1984, Volume: 26, Issue:1

    Topics: Adult; Circadian Rhythm; Humans; Hydrocortisone; Kinetics; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Prolactin

1984
Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers.
    Journal of clinical pharmacology, 1996, Volume: 36, Issue:3

    Topics: Adult; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Humans; Male; Metabolic Clearance Rate; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles

1996
Clinical pharmacology of befloxatone: a brief review.
    Journal of affective disorders, 1998, Volume: 51, Issue:3

    Topics: Adult; Aged; Brain; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Oxazoles; Placebos; Psychomotor Performance; Tyramine

1998
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.
    British journal of clinical pharmacology, 1999, Volume: 48, Issue:2

    Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1999

Other Studies

3 other study(ies) available for oxazoles and methoxyhydroxyphenylglycol

ArticleYear
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.
    Psychopharmacology, 1985, Volume: 86, Issue:3

    Topics: Animals; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones

1985
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:1

    Topics: Animals; Biogenic Monoamines; Brain; Duodenum; Humans; Liver; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Rats; Rats, Sprague-Dawley

1996
Transmitter release from Rana pipiens vestibular hair cells via mGluRs: a role for intracellular Ca(++) release.
    Hearing research, 2002, Volume: 172, Issue:1-2

    Topics: Animals; Auditory Pathways; Calcium Signaling; Electrophysiology; Hair Cells, Auditory; In Vitro Techniques; Macrocyclic Compounds; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Oxazoles; Rana pipiens; Receptors, Metabotropic Glutamate; Ryanodine; Semicircular Canals; Thapsigargin

2002